Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06300255 · ClinicalTrials.gov registry record

Evaluation of the H.O.O.V.E.S. Healing Intensives Program

A clinical trial of Depression and Anxiety, sponsored by VA Salt Lake City Health Care System.

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT06300255: Recruiting study of Depression and Anxiety, sponsored by VA Salt Lake City Health Care System.

NCT06300255 is a study of Depression and Anxiety that is actively recruiting participants, run by VA Salt Lake City Health Care System. The registered enrollment target is 250 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06300255, a study of Depression and Anxiety, is actively recruiting participants, sponsored by VA Salt Lake City Health Care System.

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to measure the impact of these H.O.O.V.E.S. healing intensives on Veteran participants using several psychological instruments. The investigators are planning to administer the demographic questionnaires and psychological instruments to Veteran participants before the healing intensives. Psychological instruments will be administered immediately pre-intervention, pre- and post-session for each session, post-intervention, 90, 120 and 360 days post-intervention. The primary aim is to assess for statistically significant changes pre- to post session and pre- to post-intervention.

Primary Outcome

AAQII is a 10-item measure that assesses psychological flexibility, with higher values indicating greater psychological inflexibility. The aim is to assess for statistically significant changes pre- to post session (1 day = a session) and pre- to post-intervention using paired t-test as well as ANCOVA adjusting for the significant demographic or diagnostic covariates.

Interventions

  • BEHAVIORAL H.O.O.V.E.S. Healing Intensives

Study Locations (1)

Utah

  • George E. Wahlen Department of Veterans Affairs Medical Center - Salt Lake City

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-04-24
Est. Completion 2029-02-01

What NCT06300255 shows while recruiting

NCT06300255 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (68% lower).

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which H.O.O.V.E.S. Healing Intensives is the first listed.

NCT06300255 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT06300255 about?

NCT06300255 is a clinical study titled "Evaluation of the H.O.O.V.E.S. Healing Intensives Program". The aim of this study is to measure the impact of these H.O.O.V.E.S. healing intensives on Veteran participants using several psychological instruments. The investigators are planning to administer the demographic questionnaires and psychological instruments to Veteran participants before the healin...

What is the current status of trial NCT06300255?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2024-04-24. Estimated completion is 2029-02-01.

What conditions does trial NCT06300255 study?

This clinical trial studies the following conditions: Depression, Anxiety, PTSD.

What interventions are being tested in trial NCT06300255?

The interventions under investigation include: H.O.O.V.E.S. Healing Intensives (BEHAVIORAL).

Who is sponsoring clinical trial NCT06300255?

This trial is sponsored by VA Salt Lake City Health Care System, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06300255 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06300255's enrollment target sits among peer trials

250 173rd of 679 higher than 505 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06300255, the US trial registry maintained by the National Library of Medicine. NCT06300255 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.